Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C7LF
|
||||
Former ID |
DIB003694
|
||||
Drug Name |
DACOPAFANT
|
||||
Synonyms |
RP-55778; Dacopafant < Rec INN >; (+)-3(R)-(3-Pyridyl)-1H,3H-pyrrolo[1,2-c]thiazole-7-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Septic shock [ICD9: 785.52; ICD10:A41.9] | Discontinued in Phase 1 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C12H11N3OS
|
||||
Canonical SMILES |
NC(=O)c1ccn2C(SCc12)c3cccnc3
|
||||
InChI |
1S/C12H11N3OS/c13-11(16)9-3-5-15-10(9)7-17-12(15)8-2-1-4-14-6-8/h1-6,12H,7H2,(H2,13,16)
|
||||
InChIKey |
ARFOASMERCHFBY-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 125372-33-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Antagonist | [2], [3] | |
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Staphylococcus aureus infection | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
Reactome | Class A/1 (Rhodopsin-like receptors) | ||||
G alpha (q) signalling events | |||||
Interferon gamma signaling | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Interferon gamma signaling | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000051) | ||||
REF 2 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. | ||||
REF 3 | RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release. J Lipid Mediat. 1989 Nov-Dec;1(6):349-60. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.